These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5848057)

  • 21. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anorexigenic activity of L(-) DOPA in animals pretreated with monoaminoxidase inhibitor.
    MANTEGAZZA P; RIVA M
    Med Exp Int J Exp Med; 1961; 4():367-73. PubMed ID: 14469449
    [No Abstract]   [Full Text] [Related]  

  • 23. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsant properties of some newer monoamine oxidase inhibitors.
    Kohli RP; Gupta TK; Parmar SS; Arora RC
    Jpn J Pharmacol; 1967 Sep; 17(3):409-15. PubMed ID: 5300187
    [No Abstract]   [Full Text] [Related]  

  • 25. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological approach to the mechanism of potentiation of hypnotics by various monoamine oxidase inhibitors].
    Simon P; Tillement JP; Lwoff JM; Boissier JR
    Therapie; 1968; 23(4):849-61. PubMed ID: 5744593
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sleep and monoamines].
    Jouvet M
    Bull Schweiz Akad Med Wiss; 1966 Dec; 22(4):287-305. PubMed ID: 5300838
    [No Abstract]   [Full Text] [Related]  

  • 28. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs.
    Torchiana ML; Wenger HC; Stavorski J; Ludden CT; Stone CA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):242-52. PubMed ID: 5932601
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of heterocyclic hydrazones of pyridoxal phosphate. Coenzymic action].
    Duhault J; Gonnard P; Fenard S
    Bull Soc Chim Biol (Paris); 1967; 49(2):177-90. PubMed ID: 6055270
    [No Abstract]   [Full Text] [Related]  

  • 32. FA-70, a novel selective and irreversible monoamine oxidase-A inhibitor: effect on monoamine metabolism in mouse cerebral cortex.
    Morón JA; Pérez V; Pastó M; Lizcano JM; Unzeta M
    J Pharmacol Exp Ther; 2000 Feb; 292(2):788-94. PubMed ID: 10640319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On pharmacoogical effects on the nervous regulation of the coronary circulation].
    Kaverina NV
    Vestn Akad Med Nauk SSSR; 1966; 21(4):9-15. PubMed ID: 6002421
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physiopathology and pharmacology of myocardial necrosis].
    Laborit H
    Agressologie; 1974; 15(1):11-24. PubMed ID: 4440812
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of brain monoamine oxidase by 1,2,4-trisubstituted 5-imidazolones.
    Kumar S; Pandey BR; Parmar SS; Gallagher JR; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):163-6. PubMed ID: 6729247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminant analysis of the relationship between physical properties and the inhibition of monoamine oxidase by aminotetralins and aminoindans.
    Martin YC; Holland JB; Jarboe CH; Plotnikoff N
    J Med Chem; 1974 Apr; 17(4):409-13. PubMed ID: 4830537
    [No Abstract]   [Full Text] [Related]  

  • 38. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors].
    Baumanis EA; Kalninia IE; Iriste AA; Gorkin VZ
    Vopr Med Khim; 1981; 27(1):72-7. PubMed ID: 6781140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the hyperglycaemic effect of DOPA and dopamine.
    Håkanson R; Lundquist I; Rerup C
    Eur J Pharmacol; 1967 Mar; 1(2):114-9. PubMed ID: 6060190
    [No Abstract]   [Full Text] [Related]  

  • 40. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid.
    Knopp J
    Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.